Casi PharmaceuticalsCASIF
13F holders, Q2 2026 (June 30)1holders
1new positions
1sold out
$0.17avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holder was West Paces Advisors Inc. ($17).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $17 |
| Exits | 1 | $25 |
All 13F filers, Q1 2026 → Q2 2026: 100 shares bought and 228 shares sold, net −128 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| West Paces Advisors Inc. | 0.00% | New | 100 | $17 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.